compound_id,compound_name,source,pharmacological_class,max_phase
CHEMBL535,SUNITINIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL1336,SORAFENIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL477772,PAZOPANIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL1289926,AXITINIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL1946170,REGORAFENIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL1173655,AFATINIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL2105717,CABOZANTINIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL24828,VANDETANIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL941,IMATINIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL502835,NINTEDANIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL554,LAPATINIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL5416410,DASATINIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL939,GEFITINIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL255863,NILOTINIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL288441,BOSUTINIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL553,ERLOTINIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL1171837,PONATINIB,ChEMBL,Tyrosine kinase inhibitor,4
CHEMBL1789941,RUXOLITINIB,ChEMBL,JAK inhibitor,4
CHEMBL1201182,TEMSIROLIMUS,ChEMBL,mTOR inhibitor,4
CHEMBL1908360,EVEROLIMUS,ChEMBL,mTOR inhibitor,4
